Lactated Ringer's and PlasmaLyte in Critically Ill Adults
NCT ID: NCT03813563
Last Updated: 2019-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
12000 participants
OBSERVATIONAL
2018-01-13
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Balanced Solutions and Plasma Electrolytes
NCT03537898
Saline Against Lactated Ringers or Plasmalyte in the Emergency Department
NCT02614040
Lactated Ringer Versus Albumin in Early Sepsis Therapy
NCT01337934
Balanced Solution Versus Saline in Intensive Care Study
NCT02875873
The Effect of Fluid Resuscitation With 0.9% Sodium Chloride Versus Balanced Crystalloid Solution on Renal Function of Sepsis Patients
NCT03277677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mix group
Patients who used two balanced salt solutions during icu stay
RL
lactated Ringer's
PLA
PlasmaLyte
RL group
Patients who have only used lactated Ringer's during icu stay
RL
lactated Ringer's
PLA group
Patients who have only used PlasmaLyte during icu stay
PLA
PlasmaLyte
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RL
lactated Ringer's
PLA
PlasmaLyte
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who stay less than 24 hours in ICU
* Patients who do not sufficient data for further analysis
* Readmission patients during the study period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West China Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kang Yan
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Critical care medicine of West China Hospital
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RL vs Plalyte
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.